Latest News
Take out two chipmakers, and the index's third-quarter earnings growth rate falls by almost a third. So why are both stocks far below their peaks?
Via The Motley Fool · October 21, 2026
Marvell's AI-driven growth prospects and forecast of nearly 10x revenue by 2031 make the recent chip-stock sell-off look like a buying opportunity.
Via The Motley Fool · October 21, 2026
The fuel cell maker has raised its 2026 outlook twice. Does the stock need a third raise?
Via The Motley Fool · October 21, 2026
Simply Good Foods (NASDAQ:SMPL): A Quality Stock With a Top-Line Caveatchartmill.com
Via Chartmill · October 21, 2026
ENERSYS (NYSE:ENS): A Growth-at-a-Reasonable-Price Industrial Candidatechartmill.com
Via Chartmill · October 21, 2026
The market is in shaky territory, and the right strategy is more important than ever.
Via The Motley Fool · October 21, 2026
The company is widening its participation in a U.S. Navy program to update countermeasures for military aircraft.
Via The Motley Fool · October 21, 2026
Maximus (NYSE:MMS) said it has agreed to acquire privately held Agile Defense for $660 million, with a potential future earn-out of up to $50 million, as the government-services company seeks to expand its presence in defense, national security and technology-intensive federal missions.
The transac
Via MarketBeat · October 21, 2026
Tesla’s new spectacular feat of engineering won't necessarily translate into stronger revenue and earnings growth.
Via The Motley Fool · October 21, 2026
Cathie Wood has provocative ideas and has delivered some strong returns, but her firm's flagship ETF could be a risky bet for the future.
Via The Motley Fool · October 21, 2026
Spero Therapeutics (NASDAQ:SPRO) plans to initiate a Phase II trial of its lead immunology candidate, SP001, in immunoglobulin G4-related disease, or IgG4-RD, in the second quarter of 2027, Chief Executive Officer Esther Rajavelu said during a company presentation.
SP001 is a third-generation anti-
Via MarketBeat · October 21, 2026
Will the U.S. debt crisis end in massive inflation?
Via The Motley Fool · October 21, 2026
Cross-border banking company East West Bancorp (NASDAQ:EWBC) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 10.3% year o...
Via StockStory · October 21, 2026
Wintrust Financial’s third quarter delivered another period of consistent growth, as the company exceeded Wall Street’s revenue expectations and saw a positi...
Via StockStory · October 21, 2026
Industrial conglomerate GE Aerospace (NYSE:GE) beat Wall Street’s revenue expectations in Q3 2026, with sales up 17.5% year on year to $13.29 billion. Its no...
Via StockStory · October 21, 2026
Consumer financial services company Synchrony Financial (NYSE:SYF) met Wall Street’s revenue expectations in Q3 2026, but sales were flat year on year at $3....
Via StockStory · October 21, 2026
Infrastructure and agriculture equipment manufacturer Valmont Industries (NYSE:VMI) fell short of the market’s revenue expectations in Q3 2026, but sales ros...
Via StockStory · October 21, 2026
Regional banking company KeyCorp (NYSE:KEY) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.3% year on year to $2.05 billion. Its non-GAAP...
Via StockStory · October 21, 2026
Security and aerospace company Northrop Grumman (NYSE:NOC) met Wall Street’s revenue expectations in Q3 2026, with sales up 6.7% year on year to $11.12 billi...
Via StockStory · October 21, 2026
Western Alliance’s third quarter results were shaped by notable progress on three fronts: asset quality improvement, deposit cost reduction, and enhanced cap...
Via StockStory · October 21, 2026
Crown Holdings’ third quarter reflected strong global demand for beverage cans, with management highlighting 6% volume growth across key regions as the main ...
Via StockStory · October 21, 2026
Financial services company Capital One (NYSE:COF) met Wall Street’s revenue expectations in Q3 2026, with sales up 5.5% year on year to $16.31 billion. Its n...
Via StockStory · October 21, 2026
RLI’s third quarter was marked by disciplined underwriting and strong investment income, resulting in a positive market reaction. Management pointed to an 86...
Via StockStory · October 21, 2026
Automotive manufacturer General Motors (NYSE:GM) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 2.9% year on year to $50.02 b...
Via StockStory · October 21, 2026
F.N.B. Corporation’s third quarter was marked by continued growth in both its loan and deposit base, with management attributing performance to robust commer...
Via StockStory · October 21, 2026